Skip to main content

Table 1 Patient characteristics

From: Study of inter- and intra-observer reproducibility in the interpretation of [18F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment

Characteristics

Value

Age (years)

 

 Average

71

 Min to max

57 to 86

 Median

72

Initial PSA level (ng/ml)

 

 Average

14.77

 Min to max

1.5 to 63

 Median

9.80

PSA level; at the time of the PET/CT request (ng/ml)

 

 Average

6.43

 Min to max

0.35 to 154

 Median

2.73

Gleason score

 

 ≤7

56

 >7

4

 NA

5

TNM Stage

 

 Any T2Nx

2

 Any T2N0M0

18

 Any T2N1M0

1

 Any T1c N0 or Nx

15

 Any T3N0M0

8

 Any T3N1

5

 Any T3Nx

3

 NA

8

Initial treatment

 

 Surg. Only

9

 Surg. A nd RT

8

 Surg. RT and HT

2

 RT only

34

 Brachytherapy only

5

Time to double PSA (months)

 

 >12 months

6

 = 12 months

8

 <12 months

5

 <6 months

4

 ≤3 months

5

 NA

32

Velocity (ng/ml/year)

 

 Average

2.87

 Min to max

0.05 to 15.45

 Median

2.03

  1. PSA, prostatic specific antigen; TNM, tumor nodes metastasis; RT, radiotherapy; HT, hormone therapy.